Infection | FXa generation (nM) |
---|
None (vehicle) | 0 |
RacL11D752 | 2.24 ± 0.18* |
RacL11N752 | 1.71 ± 0.02 |
Ab4D752 | 1.85 ± 0.10 |
Ab4N752 | 1.78 ± 0.08 |
- Monocyte-enriched PBMC fractions were infected with wild type RacL11D752 and Ab4D752 strains and engineered mutant strains (RacL11N752, Ab4N752) at an MOI of 5. Procoagulant activity was measured at 4 h after infection or vehicle (PBS) treatment (n = 4).
- * p < 0.05 versus mutant strain. All EHV-1 infected cells had significantly higher mean procoagulant activity than vehicle-treated cells.